Astellas Pharma Competitors and Similar CompaniesClear all
Astellas Pharma's competitors and similar companies include Bayer, Nipro, Shionogi, Urovant Sciences and Viatris.
 Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  Nipro Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions. |  Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. | ||
Founding Date | Founding Date 1923 | Founding Date 1863 | Founding Date 1954 | Founding Date 1878 | Founding Date 2016 | Founding Date 2020 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Irvine, US HQ Basel, CH | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | ||
Employees | Employees 14,754 | Employees 92,8152% decrease | Employees 38,117 | Employees 4,955 | Employees 3950% increase | Employees 38,0003% increase |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 27.1 b | Valuation ($) 1.5 b | Valuation ($) 12.3 b | Valuation ($) N/A | Valuation ($) 14 b |
Financial | ||||||
Revenue (est.) | Revenue (est.) ¥1.9t (FY, 2025) | Revenue (est.) €46.6b (FY, 2024) | Revenue (est.) ¥644.6b (FY, 2025) | Revenue (est.) ¥410.1b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $14.7b (FY, 2024) |
Cost of goods | Cost of goods ¥150.1b (FY, 2025) | Cost of goods €12b (FY, 2024) | Cost of goods ¥388.1b (FY, 2025) | Cost of goods ¥39.3b (FY, 2024) | Cost of goods N/A | Cost of goods $9.1b (FY, 2024) |
Gross profit | Gross profit ¥1.8t (FY, 2025) | Gross profit €35.8b (FY, 2024) | Gross profit ¥256.5b (FY, 2025) | Gross profit ¥395.8b (FY, 2024) | Gross profit N/A | Gross profit $5.6b (FY, 2024) |
Net income | Net income ¥50.7b (FY, 2025) | Net income (€2.5b) (FY, 2024) | Net income ¥6.7b (FY, 2025) | Net income ¥160.6b (FY, 2024) | Net income ($146.7m) (FY, 2020) | Net income ($634.2m) (FY, 2024) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries 83 (FY, 2021) | Countries N/A | Countries N/A | Countries N/A | Countries 165 (Q1, 2023) |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised N/A | Total funding raised $ 4.7m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Bayer
HQ
Leverkusen, DE
Employees
92,815↓ 2% decrease
Bayer is a life sciences company specializing in healthcare and nutrition.
View companyNipro
HQ
Settsu, JP
Employees
38,117
Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business.
View companyShionogi
HQ
Osaka, JP
Employees
4,955
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View companyUrovant Sciences
HQ
Irvine, US
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
View company